Cargando…
microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation
As the most frequently diagnosed non-skin cancer in men and a leading cause of cancer-related death, understanding the molecular mechanisms that drive treatment resistance in prostate cancer poses a significant clinical need. Radiotherapy is one of the most widely used treatments for prostate cancer...
Autores principales: | Labbé, Maureen, Hoey, Christianne, Ray, Jessica, Potiron, Vincent, Supiot, Stéphane, Liu, Stanley K., Fradin, Delphine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087366/ https://www.ncbi.nlm.nih.gov/pubmed/32293453 http://dx.doi.org/10.1186/s12943-020-01186-6 |
Ejemplares similares
-
Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer
por: Ollivier, Luc, et al.
Publicado: (2021) -
MicroRNAs as Biomarkers for Ionizing Radiation Injury
por: Jia, Meng, et al.
Publicado: (2022) -
MicroRNA-198 suppresses prostate tumorigenesis by targeting MIB1
por: Ray, Jessica, et al.
Publicado: (2019) -
Improved Functionality of the Vasculature during Conventionally Fractionated Radiation Therapy of Prostate Cancer
por: Potiron, Vincent A., et al.
Publicado: (2013) -
Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors
por: Autin, Pierre, et al.
Publicado: (2019)